Other Expense (Income), Net

9 Months Ended

Sep. 30, 2019

Component of Operating Income [Abstract]

OTHER EXPENSE (INCOME), NET

NOTE 16. OTHER EXPENSE (INCOME), NET

The components of Other expense (income), net for the three and nine months ended September 30, 2019 and 2018 are as follows (in thousands):

	Three Months Ended September 30,						Nine Months Ended September 30,
	2019			2018			2019			2018
Net gain on sale of business and other assets (1)	$	(1,933	)	$	(2,866	)	$	(3,101	)	$	(29,859	)
Foreign currency loss (gain), net (2)	579			1,354			4,336			(734		)
Net loss from our investments in the equity of other companies (3)	191			842			2,546			3,163
Other miscellaneous, net (4)	17,366			(837		)	16,627			(5,786		)
Other expense (income), net	$	16,203		$	(1,507	)	$	20,408		$	(33,216	)

__________

(1) Amounts primarily relate to the sales of various ANDAs.

(2) Amounts relate to the remeasurement of the Company’s foreign currency denominated assets and liabilities.

(3) Amounts relate to the income statement impacts of our investments in the equity of other companies, including investments accounted for under the equity method.

(4)

Amounts during the three and nine months ended September 30, 2019 primarily relate to $17.5 million of contract termination costs incurred as a result of certain product discontinuation activities in our International Pharmaceuticals segment.